Trending...
- InventHelp Inventor Develops New Accessory for Fishermen (TGR-242)
- Tampa-Based Digital Marketing Agency Launches New Website to Help Local Businesses Grow Online
- myb.day Launches New Birthday Gift Shop Filled With Personalized Surprises
JACKSONVILLE, Fla., May 5, 2023 ~ The American Association of Clinical Endocrinology (AACE) has unveiled the 2023 Comprehensive Type 2 Diabetes Management Algorithm at their Annual Meeting in Seattle. This algorithm provides concise guidance to healthcare professionals for the management of Type 2 diabetes (T2D).
The algorithm was written by a team of experts from AACE's global community of endocrinologists and endocrine care team members, and builds on previous versions to include the most recent evidence-based recommendations for the care and treatment of T2D. It incorporates a person-centered approach to care with a greater emphasis on associated conditions, complications and health equity.
According to Susan L. Samson, M.D., Ph.D., FRCPC, FACE, president-elect of AACE, "the paradigm of diabetes treatment has changed from a strict focus on glucose control and a one-size-fits-all approach, to a personalized assessment that considers a person's existing risks for cardiac events or kidney failure, so we can choose the right medication to decrease those risks". The algorithm also includes medication cost and access as factors related to health equity that should be considered in clinical decision-making.
More on Washingtoner
The 2023 algorithm supplements AACE's 2022 Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan. Key elements include considerations for lifestyle modification and treatment of overweight and obesity, as well as treatment of cardiovascular risk factors as pillars in the management of prediabetes and diabetes. It also provides easy-to-access immunization recommendations for people with T2D based on guidance from the Centers for Disease Control and Prevention (CDC).
AACE is pleased to share this comprehensive guide which they hope will promote better outcomes for patients with T2D. The algorithm is available online and can also be found in the May issue of Endocrine Practice, the journal of AACE.
The algorithm was written by a team of experts from AACE's global community of endocrinologists and endocrine care team members, and builds on previous versions to include the most recent evidence-based recommendations for the care and treatment of T2D. It incorporates a person-centered approach to care with a greater emphasis on associated conditions, complications and health equity.
According to Susan L. Samson, M.D., Ph.D., FRCPC, FACE, president-elect of AACE, "the paradigm of diabetes treatment has changed from a strict focus on glucose control and a one-size-fits-all approach, to a personalized assessment that considers a person's existing risks for cardiac events or kidney failure, so we can choose the right medication to decrease those risks". The algorithm also includes medication cost and access as factors related to health equity that should be considered in clinical decision-making.
More on Washingtoner
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
The 2023 algorithm supplements AACE's 2022 Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan. Key elements include considerations for lifestyle modification and treatment of overweight and obesity, as well as treatment of cardiovascular risk factors as pillars in the management of prediabetes and diabetes. It also provides easy-to-access immunization recommendations for people with T2D based on guidance from the Centers for Disease Control and Prevention (CDC).
AACE is pleased to share this comprehensive guide which they hope will promote better outcomes for patients with T2D. The algorithm is available online and can also be found in the May issue of Endocrine Practice, the journal of AACE.
Filed Under: Business
0 Comments
Latest on Washingtoner
- The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
- $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
- SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
- New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories
- The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
- Wall Street analysts say BTC.XRP.DOGE cloud mining company SIX MINING is expected to achieve a 5-fold increase, allowing users to easily mine BTC
- Gen X Takes The Reins: New Book Guides Caregivers Juggling Parents, Kids, And Grandkids With Humor And Heart
- Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
- ABM for Good™ Launches First Project with Build Change
- Lucky Envelope Brewing hosts My Name Story Exhibit by Judy Lee
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- PNNL's Grid Storage Launchpad honored with 2025 BCI Innovation Award
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador